glp 1 and dpp 4 inhibitors DPP4 vs GLP-1 Agonists | June 2021 | Clinical Corner DPP4 Inhibitors vs GLP-1 Agonists

Learn the records and tests that prove exposure, diagnosis, and causation to build a stronger case.

Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.

A group of medications called GLP-1 agonists, originally used for diabetes, may help protect kidneys and improve heart health

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

Lisa S

Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimers and addiction.